SCI Abstract

search
Cognitive reserve and its contribution to predicting cognitive performance in multiple sclerosis
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Lost in space, lost in time: A clinician’s proposed approach to the diagnosis of multiple sclerosis
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Real-world effectiveness and safety of ofatumumab in relapsing multiple sclerosis: A multicenter cohort study
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Post-infusion observation of patients with multiple sclerosis receiving natalizumab: Is it necessary?
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Is newly diagnosed multiple sclerosis a medical emergency?
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Self-harm-related mortality among U.S. decedents with multiple sclerosis: A nationwide analysis (1999–2020)
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Defining highly active multiple sclerosis: Survey bias and the interpretation of clinical definitions
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
AQP4-IgG positive and AQP4-IgG–negative NMOSD: A Multicenter Latin-American Cohort vs. a Single-Center Argentine Cohort
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Psychological resilience as a dynamic process in relapsing-remitting multiple sclerosis: A response to Alonso and Briggs
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
A visual reinterpretation of the 2024 McDonald criteria for multiple scleroris
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Inter-assay variability in anti–JC virus testing for natalizumab: A Spanish cohort
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Comparison of gait parameters and chronic lower body pain in people with multiple sclerosis
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 94f63...
Clinical characteristics associated with multiple sclerosis fatigue severity
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 94f63...
MOGAD treatment outcomes and relapse characteristics: Real world experience from a Low-Middle income country
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 94f63...
Antibody index (cerebrospinal fluid/serum) of the Epstein-Barr virus in patients with demyelinating disease
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 94f63...
Navigating a paradigm shift in the treatment of CNS demyelinating diseases in a middle-income country
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 94f63...
De-escalation of disease modifying therapies: A retrospective, observational single center study
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 94f63...